Cargando…
Development and external validation of an admission risk prediction model after treatment from early intervention in psychosis services
Early Intervention in psychosis (EIP) teams are the gold standard treatment for first-episode psychosis (FEP). EIP is time-limited and clinicians are required to make difficult aftercare decisions that require weighing up individuals’ wishes for treatment, risk of relapse, and health service capacit...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801610/ https://www.ncbi.nlm.nih.gov/pubmed/33431803 http://dx.doi.org/10.1038/s41398-020-01172-y |
_version_ | 1783635610675707904 |
---|---|
author | Puntis, Stephen Whiting, Daniel Pappa, Sofia Lennox, Belinda |
author_facet | Puntis, Stephen Whiting, Daniel Pappa, Sofia Lennox, Belinda |
author_sort | Puntis, Stephen |
collection | PubMed |
description | Early Intervention in psychosis (EIP) teams are the gold standard treatment for first-episode psychosis (FEP). EIP is time-limited and clinicians are required to make difficult aftercare decisions that require weighing up individuals’ wishes for treatment, risk of relapse, and health service capacity. Reliable decision-making tools could assist with appropriate resource allocation and better care. We aimed to develop and externally validate a readmission risk tool for application at the point of EIP discharge. All persons from EIP caseloads in two NHS Trusts were eligible for the study. We excluded those who moved out of the area or were only seen for assessment. We developed a model to predict the risk of hospital admission within a year of ending EIP treatment in one Trust and externally validated it in another. There were n = 831 participants in the development dataset and n = 1393 in the external validation dataset, with 79 (9.5%) and 162 (11.6%) admissions to inpatient hospital, respectively. Discrimination was AUC = 0.76 (95% CI 0.75; 0.77) in the development dataset and AUC = 0.70 (95% CI 0.66; 0.75) in the external dataset. Calibration plots in external validation suggested an underestimation of risk in the lower predicted probabilities and slight overestimation at predicted probabilities in the 0.1–0.2 range (calibration slope = 0.86, 95% CI 0.68; 1.05). Recalibration improved performance at lower predicted probabilities but underestimated risk at the highest range of predicted probabilities (calibration slope = 1.00, 95% CI 0.79; 1.21). We showed that a tool for predicting admission risk using routine data has good performance and could assist clinical decision-making. Refinement of the model, testing its implementation and further external validation are needed. |
format | Online Article Text |
id | pubmed-7801610 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-78016102021-01-21 Development and external validation of an admission risk prediction model after treatment from early intervention in psychosis services Puntis, Stephen Whiting, Daniel Pappa, Sofia Lennox, Belinda Transl Psychiatry Article Early Intervention in psychosis (EIP) teams are the gold standard treatment for first-episode psychosis (FEP). EIP is time-limited and clinicians are required to make difficult aftercare decisions that require weighing up individuals’ wishes for treatment, risk of relapse, and health service capacity. Reliable decision-making tools could assist with appropriate resource allocation and better care. We aimed to develop and externally validate a readmission risk tool for application at the point of EIP discharge. All persons from EIP caseloads in two NHS Trusts were eligible for the study. We excluded those who moved out of the area or were only seen for assessment. We developed a model to predict the risk of hospital admission within a year of ending EIP treatment in one Trust and externally validated it in another. There were n = 831 participants in the development dataset and n = 1393 in the external validation dataset, with 79 (9.5%) and 162 (11.6%) admissions to inpatient hospital, respectively. Discrimination was AUC = 0.76 (95% CI 0.75; 0.77) in the development dataset and AUC = 0.70 (95% CI 0.66; 0.75) in the external dataset. Calibration plots in external validation suggested an underestimation of risk in the lower predicted probabilities and slight overestimation at predicted probabilities in the 0.1–0.2 range (calibration slope = 0.86, 95% CI 0.68; 1.05). Recalibration improved performance at lower predicted probabilities but underestimated risk at the highest range of predicted probabilities (calibration slope = 1.00, 95% CI 0.79; 1.21). We showed that a tool for predicting admission risk using routine data has good performance and could assist clinical decision-making. Refinement of the model, testing its implementation and further external validation are needed. Nature Publishing Group UK 2021-01-11 /pmc/articles/PMC7801610/ /pubmed/33431803 http://dx.doi.org/10.1038/s41398-020-01172-y Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Puntis, Stephen Whiting, Daniel Pappa, Sofia Lennox, Belinda Development and external validation of an admission risk prediction model after treatment from early intervention in psychosis services |
title | Development and external validation of an admission risk prediction model after treatment from early intervention in psychosis services |
title_full | Development and external validation of an admission risk prediction model after treatment from early intervention in psychosis services |
title_fullStr | Development and external validation of an admission risk prediction model after treatment from early intervention in psychosis services |
title_full_unstemmed | Development and external validation of an admission risk prediction model after treatment from early intervention in psychosis services |
title_short | Development and external validation of an admission risk prediction model after treatment from early intervention in psychosis services |
title_sort | development and external validation of an admission risk prediction model after treatment from early intervention in psychosis services |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801610/ https://www.ncbi.nlm.nih.gov/pubmed/33431803 http://dx.doi.org/10.1038/s41398-020-01172-y |
work_keys_str_mv | AT puntisstephen developmentandexternalvalidationofanadmissionriskpredictionmodelaftertreatmentfromearlyinterventioninpsychosisservices AT whitingdaniel developmentandexternalvalidationofanadmissionriskpredictionmodelaftertreatmentfromearlyinterventioninpsychosisservices AT pappasofia developmentandexternalvalidationofanadmissionriskpredictionmodelaftertreatmentfromearlyinterventioninpsychosisservices AT lennoxbelinda developmentandexternalvalidationofanadmissionriskpredictionmodelaftertreatmentfromearlyinterventioninpsychosisservices |